Cannabinoids Market is Anticipated to Attain US$ 154.2 Billion at a CAGR of 22.2% by 2031: Transparency Market Research
Rise in R&D activities to drive the usage of cannabis for a range of medical conditions, such as chronic pain, multiple sclerosis, and epilepsy, is anticipated to fuel the usage of tetrahydrocannabinol (THC) and cannabidiol (CBD) (key cannabinoids) Rise in R&…
Wilmington, Delaware, United States, Aug. 18, 2023 (GLOBE NEWSWIRE) — Transparency Market Research Inc. – Legalization of medical marijuana (cannabis-based medicines) in several countries around the…